What Oruka Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 63 | 145 |
| Total trades | 83 | 207 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 317,458 | 4,413,602 |
| Disposed | 223,895 | 4,110,142 |
| Net activity | +93,563 | +303,460 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Goncalves Joana | Chief Medical Officer | Nov 16 | Open-market sale · S | −500 | $105.86 | −$52.9K | 31,771 |
| Goncalves Joana | Chief Medical Officer | Nov 16 | Open-market sale · S | −200 | $103.36 | −$20.7K | 32,271 |
| Goncalves Joana | Chief Medical Officer | Nov 16 | Open-market sale · S | −300 | $102.47 | −$30.7K | 32,471 |
| Goncalves Joana | Chief Medical Officer | Nov 16 | Open-market sale · S | −1,900 | $101.53 | −$193K | 32,771 |
| Goncalves Joana | Chief Medical Officer | Nov 16 | Open-market sale · S | −1,500 | $100.48 | −$151K | 34,671 |
| Goncalves Joana | Chief Medical Officer | Nov 16 | Open-market sale · S | −2,600 | $99.52 | −$259K | 36,171 |
| Goncalves Joana | Chief Medical Officer | Nov 16 | Exercise / conversion · M | +3,500 | $7.80 | +$27.3K | 38,771 |
| Goncalves Joana | Chief Medical Officer | Nov 16 | Exercise / conversion · M | +3,500 | $6.84 | +$23.9K | 35,271 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Open-market sale · S | −100 | $107.00 | −$10.7K | 14,219 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Open-market sale · S | −958 | $106.18 | −$102K | 14,319 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Open-market sale · S | −6,842 | $105.28 | −$720K | 15,277 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Open-market sale · S | −799 | $104.25 | −$83.3K | 22,119 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Open-market sale · S | −801 | $103.16 | −$82.6K | 22,918 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Open-market sale · S | −500 | $101.98 | −$51K | 23,719 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Exercise / conversion · M | +1,458 | $34.39 | +$50.1K | 24,219 |
| Agarwal Arjun | Senior Vice President, Finance | Nov 12 | Exercise / conversion · M | +8,542 | $12.50 | +$107K | 22,761 |
| Ball Kristine M | Director | Nov 12 | Open-market sale · S | −200 | $106.99 | −$21.4K | 0 |
| Ball Kristine M | Director | Nov 12 | Open-market sale · S | −2,500 | $106.05 | −$265K | 200 |
| Ball Kristine M | Director | Nov 12 | Open-market sale · S | −10,765 | $105.31 | −$1.13M | 2,700 |
| Ball Kristine M | Director | Nov 12 | Open-market sale · S | −2,039 | $104.16 | −$212K | 13,465 |
Loading...